Renalytix (LSE:RENX) Total Liabilities : £10.13 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix Total Liabilities?

Renalytix's Total Liabilities for the quarter that ended in Dec. 2024 was £10.13 Mil.

Renalytix's quarterly Total Liabilities declined from Jun. 2024 (£12.44 Mil) to Sep. 2024 (£12.18 Mil) and declined from Sep. 2024 (£12.18 Mil) to Dec. 2024 (£10.13 Mil).

Renalytix's annual Total Liabilities increased from Jun. 2022 (£15.80 Mil) to Jun. 2023 (£18.74 Mil) but then declined from Jun. 2023 (£18.74 Mil) to Jun. 2024 (£12.44 Mil).

Renalytix Total Liabilities Historical Data

The historical data trend for Renalytix's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Total Liabilities Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

4.26

5.33

15.80

18.74

12.44

Renalytix Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															15.17	15.65	12.44	12.18	10.13

Renalytix Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Renalytix's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.035	+	(3.404	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	12.44

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	6.266	-	-6.173
	=	12.44

Renalytix's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.643	+	(6.49	+	-8.8817841970013E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	10.13

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	9.05	-	-1.083
	=	10.13

Renalytix Total Liabilities Related Terms

Thank you for viewing the detailed overview of Renalytix's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

RNLXY:USA RENXF:USA 2O9A:Germany

Address

2 Leman Street, London, GBR, E1W 9US

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease diagnosis and prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix Headlines

From GuruFocus

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014